Future of Life Sciences: IBM Watson Health's Vision for Smarter Healthcare




This white paper podcast is part of DIA’s White Paper Library
The global pandemic, even with its disruption and tumult, helped the healthcare industry rediscover that necessity is the mother of invention. “It probably catapulted the life sciences industry forward by at least five to ten years, in terms of forcing us to embrace digital transformation, and everything that means. The challenge we have going forward is: How do we adopt and continue to adapt this technology so that it can be integrated into the new way of working and the new way of thinking?” suggests Lorraine Marchand, Vice President and General Manager, IBM Watson Health. “We saw an unprecedented amount of collaboration across all stakeholders to sort of redesign the plane while they were flying it,” continues IBM Watson Health Deputy Chief Health Officer Robert DiCicco. “We learned which technologies were reasonably easy to implement, and which added value, so things like telemedicine had tremendous uptake and ought to be able to provide a better patient experience moving forward.”
The global pandemic, even with its disruption and tumult, helped the healthcare industry rediscover that necessity is the mother of invention. “It probably catapulted the life sciences industry forward by at least five to ten years.” suggests Lorraine Marchand, Vice President and General Manager, IBM Watson Health. But are we where we should be, and what’s next? Join us to learn how data and technology will shape the future of healthcare, and how IBM Watson Health plans to tackle some of the most critical challenges facing Life Sciences today.


Lorraine.png Rob.png
Lorraine Marchand
Vice President and General Manager
  
  
Robert DiCicco
Deputy Chief Health Officer 








Download Now!
INTERESTED IN PUBLISHING?

For more information on publishing your White Paper with DIA, including schedule and pricing, please contact Heej Ko at [email protected].